- Motley Fool•last year
Big Pharma Merck is scheduled to report its second-quarter earnings results on July 28. Here are three questions investors are expecting to have answered on that date.
- CNBC•2 years ago
Activist hedge fund Sarissa Capital will nominate two directors to Ariad Pharmaceuticals' board and seek the "imminent retirement" of Chief Executive Harvey Berger.
- Investor's Business Daily•2 years ago
Drugmakers aim to help people live healthier lives, but they aren't immune to patent losses. Merck (MRK), which has recently faced a number of patent expirations, on Tuesday reported Q2 sales that slowed ...
Requested symbol wasn't found
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
|Day's range||0.00 - 0.00|
Trade prices are not sourced from all markets
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|